Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
Please note that all translations are automatically generated. Click here for the English version.
13.2K Views
•
08:33 min
•
February 28th, 2016
DOI :
February 28th, 2016
•Anke Van der Perren1, Cindy Casteels2, Koen Van Laere2, Rik Gijsbers3,4, Chris Van den Haute1,4, Veerle Baekelandt1
1Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, 2Division of Nuclear Medicine, Leuven University Hospital - KU Leuven, 3Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 4Leuven Viral Vector Core, KU Leuven
Przeglądaj więcej filmów
Rozdziały w tym wideo
0:05
Title
1:11
Stereotactic Injection of rAAV-α-SYN into the Rat Substantia Nigra
5:18
Results: Neurodegeneration Induced by rAAV2/7 α-SYN
7:30
Conclusion
Powiązane Filmy
10:32
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
54.9K Views
10:09
Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
51.0K Views
08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
31.5K Views
09:44
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
21.2K Views
04:08
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
2.7K Views
06:09
Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
4.4K Views
Stereotaxic Intracranial Delivery of Chemicals, Proteins or Viral Vectors to Study Parkinson's Disease
3.6K Views
08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
10.4K Views
14:45
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
5.8K Views
01:31
Generowanie szczurzego modelu 6-hydroksydopaminy choroby Parkinsona
96 Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone